Abbott 2Q 2Q Revenues: $7.5 billion (+3%) 2Q Earnings: $1.3 billion (-3%) YTD Revenues: $14.2 billion (+1%) YTD Earnings: $2.7 billion (+21%) Comments: Worldwide pharmaceutical sales were $3.9 billion (-4%). Depakote sales were down 75% to $102 million due to generic competition. Humira sales were $1.3 billion (+20%). Kaletra sales were $343 million (-4%). TriCor/Trilipix sales were $336 million (+9%). Lupron sales were up 28% to $197 million. Worldwide vascular sales were $658 ...